We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Pharmaceutical Sciences and Drug Design

2021 Volume 1

Vitamin D Deficiency and Multiple Sclerosis: Investigating a Potential Association


, , , , , , , , , , ,
  1. Faculty of Medicine, King Faisal University, Al Ahsa, KSA.
  2. Faculty of Medicine, King Khalid University, Abha, KSA.
  3. Faculty of Medicine, Hail University, Hail, KSA.
  4. Faculty of Medicine, Xingiang medical university, Xinjiang, KSA.
  5. Faculty of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, KSA.
  6. Pharmacist, Lemon medical Group, Qassim, KSA.
  7. Faculty of Medicine, King Abdulaziz University, Jeddah, KSA.
Abstract

Multiple sclerosis, an autoimmune demyelinating illness, is a common disease in young adults. Low vitamin D levels are a risk factor associated with multiple sclerosis. Numerous regulatory functions, particularly those related to the immune system, depend on vitamin D. Following the discovery of seasonal and geographic variations in the incidence of multiple sclerosis worldwide, it was suggested 50 years ago that vitamin D may play a role in the risk of developing and relapsing multiple sclerosis. This literature review aims to investigate how vitamin D may influence the development or recurrence of multiple sclerosis. The following mesh terms were used to select 21 articles: Cholecalciferol, vitamin D, multiple sclerosis, and relapses of multiple sclerosis. In addition to the indirect beneficial effects of sunlight exposure, vitamin D appears to be crucial for the immunological mechanisms underlying multiple sclerosis. To the best of our knowledge, there is no clear consensus regarding the precise role that vitamin D plays in helping people with MS. It is recommended that more multi-center randomized clinical trials be conducted to determine whether vitamin D can prevent or treat MS.


How to cite this article
Vancouver
Brahim MMA, AlDosari OM, AlYahya SAS, AlAhmari FSM, AlMalki LZA, AlShammari AMF, et al. Vitamin D Deficiency and Multiple Sclerosis: Investigating a Potential Association. Pharm Sci Drug Des. 2021;1:27-31. https://doi.org/10.51847/ZSQz93acfK
APA
Brahim, M. M. A., AlDosari, O. M., AlYahya, S. A. S., AlAhmari, F. S. M., AlMalki, L. Z. A., AlShammari, A. M. F., AlBahrani, A. K., AlBahrani, T. A., AlJabr, S. Z., AlRashdi, F. M., et al. (2021). Vitamin D Deficiency and Multiple Sclerosis: Investigating a Potential Association. Pharmaceutical Sciences and Drug Design, 1, 27-31. https://doi.org/10.51847/ZSQz93acfK

About GalaxyPub

Find out more

Galaxy Publication is an independent scholarly publishing platform operating under the scientific and organizational designation of Eshragh Scientific and Research Center and the legal framework of ISRAK PUBLISHER EGITIM HIZMETLERI LIMITED.

The publisher is committed to ethical, transparent, and high-quality academic publishing and supports scholarly communication through internationally aligned editorial practices, publication ethics, and responsible dissemination of scientific research.